---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-162617"
form_type: "8-K"
ticker: "AURA"
cik: "0001501796"
company_name: "Aura Biosciences, Inc."
filed_at: "2023-06-07T23:59:59+00:00"
generated_at: "2026-06-14T05:46:44.331772+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Aura Biosciences shareholders elect David Johnson and Karan Takhar as directors, ratify EY auditor

## Summary
- At the annual meeting on June 7, 2023, shareholders elected David Johnson and Karan Takhar as Class II directors until 2026, with over 13.2 million votes for each.
- The appointment of Ernst & Young as independent auditor for fiscal year 2023 was ratified with 25,725,525 votes for, 3,721 against, and 1,826 abstentions.
- Broker non-votes on director elections totaled 9,206,963; there were no broker non-votes on auditor ratification.
- Total shares present or represented were 25,731,072 out of 37,800,102 entitled to vote.

## SEC filing metadata
- accession: 0001193125-23-162617
- form_type: 8-K
- ticker: AURA
- cik: 0001501796
- company_name: Aura Biosciences, Inc.
- filed_at: 2023-06-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501796/000119312523162617/0001193125-23-162617-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501796/000119312523162617/d489468d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-162617
- JSON: https://secwatch.observer/filing/0001193125-23-162617.json
- Plain text: https://secwatch.observer/filing/0001193125-23-162617.txt

## Key facts
- Shareholder Votes
  Aura Biosciences, Inc. shareholders approved Ratification of Appointment of Independent Registered Accounting Firm at the 2023-06-07 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-07
  source text: Proposal 2 - Ratification of Appointment of Independent Registered Accounting Firm The Company’s stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023. Votes For Votes Against Abstentions 25,725,525 3,721 1,826 There were zero broker non-votes regarding this proposal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1501796/000119312523162617/0001193125-23-162617-index.htm
- Shareholder Votes
  Aura Biosciences, Inc. shareholders approved Election of Directors at the 2023-06-07 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-07
  source text: Proposal 1 - Election of Directors The Company’s stockholders elected the two (2) director nominees below to the Company’s Board of Directors as Class II directors to hold office until the 2026 Annual Meeting of Stockholders of the Company or until their successors are duly elected and qualified. Director Nominee Votes For Votes Withheld Broker Non-Votes David Johnson 13,248,297 3,275,812 9,206,963 Karan Takhar 13,248,607 3,275,502 9,206,963
  evidence_url: https://www.sec.gov/Archives/edgar/data/1501796/000119312523162617/0001193125-23-162617-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.